Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Oral Controlled Release Flecainide Acetate Capsules on Health-Related QoL in Patients With Paroxysmal Atrial Fibrillation

NCT00189319 is registered in ClinicalTrials.gov with MEDA Pharma GmbH & Co. KG as lead sponsor.

NCT NCT00189319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00189319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Oral Controlled Release Flecainide Acetate Capsules on Health-Related QoL in Patients With Paroxysmal Atrial Fibrillation
Lead sponsor
MEDA Pharma GmbH & Co. KG
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2003
Completion date
Not reported
Enrollment
200
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation